Tian Yaping

Prof. Tian Yaping

The First Bethune Hospital of Jilin University, Changchun 130021, China
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
YZYan Zhou
Yan Zhou
XJXiaoteng Jia
Xiaoteng Jia
DPDaxin Pang
Daxin Pang
SJShan Jiang
Shan Jiang
MZMeihua Zhu
Meihua Zhu
GWGordon G. Wallace
Gordon G. Wallace
Wearable transdermal iontophoresis eliminating the need for external power sources offers advantages for patient-comfort when deploying epidermal diseases treatments. However, current self-powered iontophoresis based on energy harvesters is limited to support efficient therapeutic administration over the long-term operation, owing to the low and inconsistent energy supply. Here we propose a simplified wearable iontophoresis patch with a built-in Mg battery for efficient and controllable transdermal delivery. This system decreases the system complexity and form factors by using viologen-based hydrogels as an integrated drug reservoir and cathode material, eliminating the conventional interface impedance between the electrode and drug reservoir. The redox-active polyelectrolyte hydrogel offers a high energy density of 3.57 mWh cm−2, and an optimal bioelectronic interface with ultra-soft nature and low tissue-interface impedance. The delivery dosage can be readily manipulated by tuning the viologen hydrogel and the iontophoresis stimulation mode. This iontophoresis patch demonstrates an effective treatment of an imiquimod-induced psoriasis mouse. Considering the advantages of being a reliable and efficient energy supply, simplified configuration, and optimal electrical skin-device interface, this battery-powered iontophoresis may provide a new non-invasive treatment for chronic epidermal diseases.

11 May 2024 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
JZJiaxin Zhao
Jiaxin Zhao
SGShengen Gong
Shengen Gong
YMYueming Mu
Yueming Mu
XJXiaoteng Jia
Xiaoteng Jia
YZYan Zhou
Yan Zhou
DCDanming Chao
Danming Chao

10 January 2019 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
XLXiao Li
Xiao Li
JXJian Xin Xia
Jian Xin Xia
MPMalla Padma
Malla Padma
ZMZhenghui Ma
Zhenghui Ma
TYTian Yaping
Tian Yaping

13 September 2019 in Records of Natural Products
Verified
Journal Article
Closed access
YYYong Yang
Yong Yang
TYTian Yaping
Tian Yaping
QZQinghe Zhang
Qinghe Zhang
XLXiaoqing Li
Xiaoqing Li
YFYun Fu
Yun Fu
DLDan Lu
Dan Lu
Fructus Sophorae (FS), the dry mature fruit of Sophora japonica Leguminosae, is a valuable traditional Chinese medicine resource with flavonoids as the major active ingredients. To identify the plant-derived estrogen-like flavonoids serving as potential osteoporosis chemopreventive agents, we isolated and identified 27 flavonoids compounds, including 17 compounds obtained for the first time from FS. To screen out the flavonoids with estrogen-like biological behavior from the 11 high yield compounds, we set up an in vitro screening system in rat osteoblast MC3T3-E1 cells including MTT assay, alkaline phosphatase staining and Alizarin red S staining assay to examine the effects on cell proliferation, differentiation and mineralization of osteoblast cells respectively. Six flavonoids, including genistein, sophoricoside, sophorabioside, sophoraflavonoloside, nicotiflorin and rutin, significantly increased the cellular activity of MC3T3-E1 cells. Furthermore, blocking the estrogen receptor signaling by tamoxifen compromised the effects above significantly, suggesting the 6 compounds behave as estrogen-like reagents. Moreover, the interaction between the six flavonoids from FS and estrogen receptor was clarified by molecular docking method from Glide XP. Collectively, being used as food and medicine in China, FS is rich in flavonoids with estrogen-like effects, may be used as healthy supplementary in treating postmenopausal women osteoporosis.

1 July 2019 in Nanoscale
Verified
Journal Article
Closed access
PDF file
LSLin Sun
Lin Sun
YSYang Shi
Yang Shi
MTMingcong Tang
Mingcong Tang
DWDong Wang
Dong Wang
TYTian Yaping
Tian Yaping
JLJing Li
Jing Li
The hierarchical urchin-like LaWO 4 Cl assemblies promote the photothermal conversion performance due to the localized surface plasmon resonance.

5 March 2024 in Aging
Verified
Journal Article
Open access
PDF file
JLJianing Li
Jianing Li
DPDaxin Pang
Daxin Pang
LZLin Zhou
Lin Zhou
HOHongsheng Ouyang
Hongsheng Ouyang
TYTian Yaping
Tian Yaping
HYHao Yu
Hao Yu
Psoriasis is a chronic inflammatory proliferative dermatological ailment that currently lacks a definitive cure. Employing data mining techniques, this study identified a collection of substantially downregulated miRNAs (top 10). Notably, 32 targets were implicated in both the activation of the IL-17 signaling pathway and cell cycle dysregulation. In silico analysis revealed that one of these miRNAs, miR-26a-5p, is a highly conserved cross-species miRNA. Strikingly, the miR-26a-5p sequences in humans and mice are identical, and mmu-miR-26a-5p was found to target the same 7 cell cycle targets as its human counterpart, hsa-miR-26a-5p. Among these targets, CDC6 and CCNE1 were the most effective targets of miR-26a-5p, which was further validated in vitro using a dual luciferase reporter system and qPCR assay. The therapeutic assessment of miR-26a-5p revealed its remarkable efficacy in inhibiting the proliferation and G1/S transition of keratinocytes (HaCaT and HEKs) in vitro. In vivo experiments corroborated these findings, demonstrating that miR-26a-5p effectively suppressed imiquimod (IMQ)-induced psoriasis-like skin lesions in mice over an 8-day treatment period. Histological analysis via H&E staining revealed that miR-26a-5p treatment resulted in reduced keratinocyte thickness and immune cell infiltration into the spleens of IMQ-treated mice. Mechanistic investigations revealed that miR-26a-5p induced a cascade of downregulated genes associated with the IL-23/IL-17A axis, which is known to be critical in psoriasis pathogenesis, while concomitantly suppressing CDC6 and CCNE1 expression. These findings were corroborated by qPCR and Western blot analyses. Collectively, our study provides compelling evidence supporting the therapeutic potential of miR-26a-5p as a safe and reliable endogenous small nucleic acid for the treatment of psoriasis.